Hepatocyte growth factor attenuates liver fibrosis induced by bile duct ligation
According to the Summary of Product Characteristics (SmPC), the most common side effects include: Nausea (affecting 12-24% of patients, with frequency increasing at higher doses) Diarrhoea (reported in 13-22% of participants) Vomiting (occurring in 6-10% of patients) Constipation (affecting 5-12% of users) Abdominal pain or discomfort Dyspepsia (indigestion) Decreased appetite These effects are typically mild to moderate in severity and tend to diminish over time as the body adjusts to treatment
Caruso, I., Di Gioia, L., Di Molfetta, S
Methylmercaptan increases the build-up of cathepsin B, interstitial collagenase, and interleukin-1 by mononuclear cells, all of which promote the breakdown of connective tissue
Stopping valproic acid suddenly can cause serious problems